Bleeding complications after percutaneous liver biopsy: An analysis of risk factors

Digestion

Volumn 67, Issue 3, 2003, Pages 138-145

  Terjung, Birgit ^a   Lemnitzer, Isabelle ^a   Dumoulin, Franz Ludwig ^a   Effenberger, Wolfgang ^a   Brackmann, Hans Hermann ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Bleeding complications; Hematoma; Liver biopsy; Risk factors

Indexed keywords

CORTICOSTEROID; DIPYRONE; HEMOGLOBIN; HEPARIN;

ADOLESCENT; ADULT; AGED; ANALYSIS; ARTICLE; BIOPSY TECHNIQUE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LEUKEMIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER HEMATOMA; LOGISTIC REGRESSION ANALYSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK; RISK FACTOR; SCHOOL CHILD; STATISTICAL MODEL; THROMBOCYTE; ULTRASOUND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHILD; COHORT STUDIES; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037972603     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071293     Document Type: Article

References (54)

1. Menghini G: Current concepts: One-second biopsy of the liver - problems of its clinical application. N Engl J Med 1970;283:582-585.
2. Thaler H: Über Vorteil und Risiko der Leberbiopsiemethode nach Menghini. Wien Klin Wochenschr 1964;76:533-538.
3. Lindner H: Grenzen und Gefahren der perkutanen Leberbiopsie mit der Menghini-Nadel: Erfahrungen bei 80,000 Leberbiopsien. Dtsch Med Wochenschr 1967;92:1751-1757.
4. Piccinino F, Sagnelli E, Pasquale G, Giusti G (Study group of the Clinic of Infectious Diseases, Naples): Complications following percutaneous liver biopsy: A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986, 2:165-173.
5. McGill DB, Rakela J, Zinsmeister AR, Ott BJ: A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-1400.
6. Froehlich F, Lamy O, Fried M, Gonvers JJ: Practice and complications of liver biopsy: Results of a nationwide survey in Switzerland. Dig Dis Sci 1993;38:1480-1484.
7. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A: Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: An audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995;36:437-441.
8. Cadranel JF, Rufat P, Degos F, for the Group of Epidemiology of the French Association for the Study of the Liver (AEFF): Practices of liver biopsy in France: Results of a prospective nationwide survey. Hepatology 2000;32:477-481.
9. Forsell PL, Bonkowski HL, Anderson PB, Howell DA: Intrahepatic hematoma after aspiration liver biopsy: A prospective randomized trial using two different needles. Dig Dis Sci 1981;26:631-635.
10. Hederström E, Forsberg L, Florén CH, Prytz H: Liver biopsy complications monitored by ultrasound. J Hepatol 1989;8:94-98.
11. Raines DR, Van Heertum RL, Johnson LF: Intrahepatic hematoma: A complication of percutaneous liver biopsy. Gastroenterology 1974;67:284-289.
12. Minuk GY, Sutherland LR, Wiseman DA, Mac Donald FR, Ding DL: Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bedrest after percutaneous liver biopsy. Gastroenterology 1987;92:290-293.
13. Nelson RS, Salvador DSJ: Percutaneous needle liver biopsy in malignant neoplasm with special reference to myeloid metaplasia. Ann Intern Med 1960;53:179-191.
14. Conn HO: Liver biopsy: Increased risks in patients with cancer. Hepatology 1991;14:206-209.
15. Gordon SC, Veneri RJ, McFadden RF, Reddy KR, Schiff ER: Major hemorrhage after percutaneous liver biopsy in patients with AIDS. Gastroenterology 1991;100:1787.
16. Gottesman D, Dyrszka H, Albarran J, Hilfer J: AIDS-related hepatic Kaposi's sarcoma: Massive bleeding following liver biopsy. Am J Gastroenterol 1993;88:762-764.
17. Özdogan M, Özgür O, Boyacioglu S, Coskun M, Kart H, Özdal S, Telatar H: Percutaneous liver biopsy complications in patients with chronic renal failure. Nephron 1996;74:442-443.
18. Violi F, Leo R, Davi G, Patrico D, Iuliano L, Balsano F: Thrombocytopenia and thrombocytopathia in liver cirrhosis. Platelets 1992;3:233-239.
19. Dammermann R, Budweg A, Garbe W, Gestefeld K, Grote W, Seevers HH: Abhängigkeit der Nachblutung nach Leberbiopsien von dem Nadelkaliber; in Henning H (ed): Fortschritte gastroenterologische Endoskopie. Baden-Baden, Witzstrock Verlag, 1978, pp 131-132.
20. Ewe K: Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci 1981;26:388-393.
21. Aledort LM, Levine PH, Hilgartner M, Blatt P, Spero JA, Goldberg JD, Bianchi L, Desmet V, Scheuer P, Popper H, Berk PD: A study of liver biopsies and liver disease among hemophiliacs. Blood 1985;66:367-372.
22. Mielke CH Jr, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI: The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969;34:204.
23. Van Thiel DH, Gavaler JS, Wright H, Tzakis A: Liver biopsy: Its safety and complications seen at a liver transplant center. Tranplantation 1993;55:1087-1090.
24. Sherlock S, Dick R, Van Leeuwen DJ: Liver biopsy today: The Royal Free Hospital Experience. J Hepatol 1984;1:75-85.
25. Perrault J, McGill DB, Ott BJ, Taylor WF: Liver biopsy: Complications in 1,000 patients and outpatients. Gastroenterology 1978;74:103-106.
26. Janes CH, Lindor KD: Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993;118:96-98.
27. Garcia-Tsao G, Boyer JL: Outpatient liver biopsy: How safe is it? Ann Intern Med 1993;118:150-153.
28. Reichert CM, Weisenthal LM, Klein HG: Delayed hemorrhage after percutaneous liver biopsy. J Clin Gastroenterol 1983;5:263-266.
29. Mahal AS, Knauer CM, Gregory PB: Bleeding after liver biopsy. West J Med 1981;134:11-14.
30. Trübestein G, Miederer SE, Stadelmann O: Fatal late complication of liver biopsy. Endoscopy 1973;5:161-163.
31. McVay PA, Toy PTCY: Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol 1990;94:747-753.
32. Sherlock S: Needle biopsy of the liver; in Sherlock S (ed): Diseases of the Liver and Biliary System, ed 9. Oxford, Blackwell Scientific Publications, 1993, pp 33-43.
33. Grant A, Neuberger J: Guidelines on the use of liver biopsy in clinical practice. Gut 1999;45(suppl IV):IV1-IV11.
34. Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med 2001;344:495-500.
35. Gazelle GS, Haaga JR, Rowland D: Effect of needle gauge, level of anticoagulation, and target organ on bleeding associated with aspiration biopsy. Radiology 1992;183:509-513.
36. Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-1886.
37. Concato J, Shah N, Horwitz RI: Randomized, controlled trials, obervational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892.
38. Wong VS, Baglin T, Beacham E, Wight DD, Petrik J, Alexander GJ: The role for liver biopsy in haemophiliacs infected with the hepatitis C virus. Br J Haematol 1997;97:343-347.
39. Ahmed MM, Mutimer DJ, Elias E, Linin J, Garrido M, Hubscher S, Jarvis L, Simmonds P, Wilde JT: A combined management protocol for patients with coagulation disorders infected with hepatitis C virus. Br J Haematol 1996;95:383-388.
40. Miescher PA: Blood dyscrasis secondary to non-steroidal anti-inflammatory drugs. Med Toxicol 1986;1(suppl 1):57-70.
41. Berthold H: Metamizol; in Berthold H (ed): Klinikleitfaden Arzneimitteltherapie. Lübeck, Gustav Fischer Verlag, 1999, pp 879-880.
42. Maartens G, Willcox PA, Benatar SR: Miliary tuberculosis: Rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med 1990;89:291-296.
43. Katzen H, Spagnolo V: Bone marrow necrosis from miliary tuberculosis. JAMA 1980;244:2438-2439.
44. Krauss JS, Walker DH: Miliary tuberculosis and consumption of clotting factors by multifocal vasculopathic coagulations. South Med J 1979;72:1479-1481.
45. Cowan DH, Graham RC Jr, Baunach D: The platelet defect in leukemia: Platelet ultrastructure, adenine nucleotide metabolism, and the release reaction. J Clin Invest 1975;56:188-200.
46. Schafer AI: Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984;64:1-12.
47. Mohri H: Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia. Am J Hematol 1986;22:391-401.
48. Uesugi Y, Fuse I, Toba K, Koike T, Shibata A: Acquired immune thrombocytopenia caused by IgG antiglycoprotein Ib antibody in a patient with Hodgkin's disease. Acta Haematol 1997;98:217-220.
49. Berchtold P, Harris JP, Tani P, Piro L, McMillan R: Autoantibodies to platelet glycoproteins in patients with disease-related immune thrombocytopenia. Br J Haematol 1989;73:365-368.
50. Fritz E, Ludwig H, Scheithauer W, Sinziger H: Shortened platelet half-life in multiple myeloma. Blood 1986;68:514-520.
51. Carr ME Jr, Zekert SL: Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma. Am J Physiol 1994;266:H 1195-1201.
52. Kenny CNC: Potential renal, haematological and allergic adverse effects associated with nonsteroidal anti-inflammatory drugs. Drugs 1992;44(suppl 5):31-37.
53. Neumann F, Schenck B: Glucocorticoide; in Forth W (ed): Allgemeine und spezielle Pharmakologie und Toxikologie, ed 5. Mannheim, Bibliographisches Institut & F. A. Brockhaus AG, 1987, pp 424-434.
54. Lebrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP: Transvenous liver biopsy: An experience based on 1,000 hepatic tissue samplings with this procedure. Gastroenterology 1982;83:338-340.